Prosecution Insights
Last updated: July 17, 2026
Application No. 19/072,628

HEALTH MONITORING AND COMMUNICATIONS DEVICE

Non-Final OA §103
Filed
Mar 06, 2025
Priority
Jun 05, 2015 — provisional 62/171,944 +8 more
Examiner
CHEN, XUXING
Art Unit
2176
Tech Center
2100 — Computer Architecture & Software
Assignee
Life365 Inc.
OA Round
3 (Non-Final)
86%
Grant Probability
Favorable
3-4
OA Rounds
1y 2m
Est. Remaining
98%
With Interview

Examiner Intelligence

Grants 86% — above average
86%
Career Allowance Rate
549 granted / 638 resolved
+31.1% vs TC avg
Moderate +12% lift
Without
With
+11.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
10 currently pending
Career history
656
Total Applications
across all art units

Statute-Specific Performance

§101
5.3%
-34.7% vs TC avg
§103
66.6%
+26.6% vs TC avg
§102
17.8%
-22.2% vs TC avg
§112
4.0%
-36.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 638 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claims 1, 2, 5-7, 11-18 and 21-22 are pending. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-7 and 10-22 is/are rejected under 35 U.S.C. 103 as being unpatentable over Luna et al. (hereinafter Luna) (US 20160270717 A1) in view of Lettow (US 20160327979 A1)1. As to claim 1, Luna teaches A device for being attached to a user or the user's clothing [0044: “bands 104-112 may be implemented as wearable personal data or data capture devices (e.g., data-capable devices) that are worn by a user around a wrist, ankle, arm, ear, or other appendage, or attached to the body or affixed to clothing.”], the device having a length, a width, and a thickness [band has three dimensions], the device comprising: (a) electronic circuity, a first power source, and a display [0050: “band 200 includes bus 202, processor 204…battery 214…”] [0061: “interface module 410 may be used to manage different types of displays…”]; and (c) one or more connectors [FIG. 2: communications facility 216] wherein the device is configured to communicate with and receive data from one or more medical devices [0135: “FIG. 20 depicts an example of various medical devices that can communicate with a wearable device incorporating a monitoring and feedback module.”] by: receiving data in one or more transmission protocols [0054: “communications facility 216 may be implemented to provide a “wired” data communication capability such as an analog or digital attachment, plug, jack, or the like to allow for data to be transferred. In other examples, communications facility 216 may be implemented to provide a wireless data communication capability to transmit digitally encoded data across one or more frequencies using various types of data communication protocols, without limitation.”]; reformatting the data into a format compatible for the one or more medical devices [0047] [FIG.20] [00136: It illustrate the communications between the band and the medical devices. The band provides health-related information and instructions to medical device and create a feedback loop between the band and the medical devices. The medical devices can perform execution based upon the information and instructions. It implies that the format of data is formatted into a format compatible for the medical devices.]; and transmit the data in one or more different transmission protocols [0054]; wherein the one or more medical devices are selected from one or more of: a blood glucose meter; a pacemaker; a blood pressure monitor; an insulin pump; a pulse oximeter; a Holter monitor; an electrocardiograph; an electroencephalograph; a blood alcohol monitor; an alcohol breathalyzer; an alcohol ignition interlock; a respiration monitor; an accelerometer; a skin galvanometer; a thermometer; a patient geolocation device; a scale; an intravenous flow regulator; a patient height measuring device; a biochip assay device; a monitor for biological agents; a hazardous chemical agent monitor; an ionizing radiation sensor; a sphygmomanometer; a loop recorder; a spirometer; an event monitor; a prothrombin time (PT) meter; an international normalized ratio (INR) meter; a tremor sensor; and a defibrillator [0134: “Examples of medical devices include, but are not limited to, glucose monitors, heart rate monitors, blood pressure monitors, CPAP machines, pacemakers, homocysteine level monitors, and intravenous (“IV”) monitors.”], wherein the one or more medical devices are separate and detached from the device [0135] [FIG. 20], wherein the one or more connectors comprises an optical fiber connection, a tip and sleeve (TS) connection, a tip, ring, and sleeve (TRS) connection, a tip, ring, ring, and sleeve (TRRS) connection, a serial peripheral interface bus (SPI) connection, a universal serial bus (USB) connection, an RS-232 serial connection, an Ethernet connection, or a FireWire connection [0071: “Bands 104 and 108 may communicate with mobile communications device 118 or laptop 122 using any number of known wired communication technologies (e.g., Universal Service Bus (USB) connections, TRS/TRRS connections, telephone networks, fiber-optic networks, cable networks, etc.).”], and wherein the device has a plurality of operating modes that change depending upon which of the one or more medical devices are in communication with the device [0049] [0135-0137: The various medica devices can communicate with a wearable device. Therefore, in order to support the functionalities of the medical devices, the operating mode of the wearable device will be changed based on the medica device in communication with the wearable device.]. Luna does not teach the device comprising a thickness of 1/4" or less. Lettow teaches a wearable device having a thickness of 1/4" or less [0044: “In some cases, the device cam have a maximum thickness…or of about 6mm, or of about 4mm, or of about 2mm, or of about 1mm…”]. Thus, it would have been obvious to one ordinary skill in the art before the effective filing date of the invention to incorporate the teaching of designing the thickness of ¼’’ or less as suggested in Lettow into Luna to implement fabrication of the wearable device. One having ordinary skill in the art would have been motivated to make such modification to improve user experience by reducing the size and weight of the device. As to claims 2, 5-7, 11-18, and 21-22, the rejections are respectfully maintained for the reasons as set forth in the last office action mailed on 09/03/2025. Response to Arguments Applicant's arguments filed on 03/02/2026 have been fully considered but they are not persuasive. In the remarks, Applicant argued that Lunar in view of Lettow fails to teach the new inserted limitation on the amendment filed on 03/02/26. The examiner respectfully traverses Applicant’s argument with the reasons as set forth in the rejection recited above. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to XUXING CHEN whose telephone number is (571)270-3486. The examiner can normally be reached M-F 9-5:30PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jaweed Abbaszadeh can be reached at 571-270-1640. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /XUXING CHEN/Primary Examiner, Art Unit 2176 1 Luna and Lettow was cited as prior art in the previous office action mailed on 05/08/2025.
Read full office action

Prosecution Timeline

Mar 06, 2025
Application Filed
May 08, 2025
Non-Final Rejection mailed — §103
Aug 08, 2025
Response Filed
Sep 03, 2025
Final Rejection mailed — §103
Mar 02, 2026
Request for Continued Examination
Mar 10, 2026
Response after Non-Final Action
Apr 03, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12681558
METHDO AND SYSTEM OF WIRELESS DEVICE POWER MANAGEMENT
2y 4m to grant Granted Jul 14, 2026
Patent 12681658
HEALTH MONITORING AND COMMUNICATIONS DEVICE
1y 3m to grant Granted Jul 14, 2026
Patent 12675576
SECURE BOOT AND OPERATING SYSTEM MANAGEMENT
2y 2m to grant Granted Jul 07, 2026
Patent 12663850
AUTOMATIC ON-DIE FREQUENCY TUNING USING TUNABLE REPLICA CIRCUITS
4y 0m to grant Granted Jun 23, 2026
Patent 12665766
METHOD, DEVICE, AND COMPUTER PROGRAM PRODUCT FOR SECURE CALLING
2y 0m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
86%
Grant Probability
98%
With Interview (+11.7%)
2y 7m (~1y 2m remaining)
Median Time to Grant
High
PTA Risk
Based on 638 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month